Literature DB >> 20410163

Don't use aspirin for primary prevention of cardiovascular disease.

Helen Barnett1, Peter Burrill, Ike Iheanacho.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20410163     DOI: 10.1136/bmj.c1805

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  14 in total

1.  Identifying opportunities to improve aspirin utilization for the primary prevention of cardiovascular disease in a regional health care system.

Authors:  Jeffrey J VanWormer; Aaron W Miller; H Rezkalla
Journal:  WMJ       Date:  2014-10

Review 2.  Aspirin for primary prevention of cardiovascular disease in diabetes mellitus.

Authors:  Michael Pignone; Craig D Williams
Journal:  Nat Rev Endocrinol       Date:  2010-09-21       Impact factor: 43.330

3.  Silent myocardial ischaemia and long-term coronary artery disease outcomes in apparently healthy people from families with early-onset ischaemic heart disease.

Authors:  Brian G Kral; Lewis C Becker; Dhananjay Vaidya; Lisa R Yanek; Diane M Becker
Journal:  Eur Heart J       Date:  2011-07-23       Impact factor: 29.983

4.  Associations of NSAID and paracetamol use with risk of primary liver cancer in the Clinical Practice Research Datalink.

Authors:  Baiyu Yang; Jessica L Petrick; Jie Chen; Katrina Wilcox Hagberg; Vikrant V Sahasrabuddhe; Barry I Graubard; Susan Jick; Katherine A McGlynn
Journal:  Cancer Epidemiol       Date:  2016-07-13       Impact factor: 2.984

Review 5.  Antiplatelet combinations for prevention of atherothrombotic events.

Authors:  Mario Bollati; Fiorenzo Gaita; Matteo Anselmino
Journal:  Vasc Health Risk Manag       Date:  2011-01-12

6.  Patient experience - the ingredient missing from cost-effectiveness calculations.

Authors:  David Curtis
Journal:  Patient Prefer Adherence       Date:  2011-05-30       Impact factor: 2.711

7.  Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks.

Authors:  Carmelo Scarpignato; Angel Lanas; Corrado Blandizzi; Willem F Lems; Matthias Hermann; Richard H Hunt
Journal:  BMC Med       Date:  2015-03-19       Impact factor: 8.775

8.  Aspirin for primary prevention: a challenging decision.

Authors:  Michael Pignone
Journal:  J Am Heart Assoc       Date:  2014-08-21       Impact factor: 5.501

9.  Which interventions offer best value for money in primary prevention of cardiovascular disease?

Authors:  Linda J Cobiac; Anne Magnus; Stephen Lim; Jan J Barendregt; Rob Carter; Theo Vos
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

10.  Does low-dose acetylsalicylic acid prevent cognitive decline in women with high cardiovascular risk? A 5-year follow-up of a non-demented population-based cohort of Swedish elderly women.

Authors:  Silke Kern; Ingmar Skoog; Svante Ostling; Jürgen Kern; Anne Börjesson-Hanson
Journal:  BMJ Open       Date:  2012-10-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.